PatientView

Working with patient groups to improve healthcare. #patientcentricity #Pharma #reputation and most recent #PAGC19 Also see

[PatientView @PatientView]

🔊 SOUND ON

Transforming the patient voice into meaningful action

For 20 years, PatientView has been capturing the authentic voice of patient groups to help pharmaceutical companies improve their relationships with patient groups.

[PatientView @PatientView]

𝗪𝗼𝗿𝗹𝗱 𝗣𝗿𝗼𝘀𝘁𝗮𝘁𝗲 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆: 𝗪𝗵𝘆 𝗴𝗹𝗼𝗯𝗮𝗹 𝗮𝗰𝘁𝗶𝗼𝗻 𝗶𝘀 𝗻𝗲𝗲𝗱𝗲𝗱
Prostate cancer's the most commonly diagnosed cancer in men in 100+ countries, yet approaches to screening, diagnosis, & care remain inconsistent.
Read more:https://t.co/C8C3Xw1Hl1

[PatientView @PatientView]

Today, the Corporate Reputation of Pharma 2025/26, Canada Edition has been published.

For more information, including industry-wide findings and the top-ranking pharma companies in Canada, read the press release: https://t.co/1Rrx40QJ3U

[PatientView @PatientView]

ViiV Healthcare has ranked #1 for the 13th consecutive year in the PatientView Corporate Reputation of Pharma survey.
Given the company’s consistently high rankings, we recently spoke with Ama Appiah, Patient Affairs Lead, at ViiV Healthcare.
Read the Q&A: https://t.co/lgh2Dscn2m

[PatientView @PatientView]

“How do four key pharma companies address R&D demands from patient groups?”
Find answers to this question in 'What Companies Say 2025-2026', with contributions from Boehringer Ingelheim, Novartis, Servier, and ViiV Healthcare. Access the publication here: https://t.co/RUNpekxQcP

[PatientView @PatientView]

Friday 15th – USA press release
The Corporate Reputation of Pharma 2025/26 - USA Edition is now available

To learn more about the changes in the corporate reputation of the US pharma industry and individual pharma companies, read the press release: https://t.co/1Rrx40QJ3U

[PatientView @PatientView]

This Thursday, PatientView will release The Corporate Reputation of Pharma 2025/26 – Global Edition.
Results will reveal how the pharma industry and pharma companies have performed in 2025, drawing on 2,403 patient group perspectives.
Contact [email protected] for details

[PatientView @PatientView]

This is a final call to patient groups!
Today is the last day to participate in the PatientView Corporate Reputation of Pharma 2025 Survey.
Help us shape the future of healthcare and participate!
Access the survey in your preferred language: https://t.co/eTvbislOSd

[PatientView @PatientView]

There's just 1 day left to complete the PatientView Corporate Reputation of Pharma 2025 Survey.

By filling out the short survey, you can help strengthen the patient voice & shape the future of healthcare.

Complete the survey in your preferred language: https://t.co/SXOKRDotQo

[PatientView @PatientView]

We're calling on patient groups - the clock is ticking!
There are only two days left to complete the PatientView Corporate Reputation of Pharma 2025 Survey.
This is your chance to be part of the movement, complete the survey here: https://t.co/eTvbislh2F

[PatientView @PatientView]

This is a call to patient groups, there are just 3 days left to complete the PatientView Corporate Reputation of Pharma 2025 Survey!

Your insights are powerful, and they deserve to be heard.

Complete the short survey here: https://t.co/eTvbislh2F

[PatientView @PatientView]

Patient groups, the 1-week countdown has officially begun! You have just 7 days left to complete the PatientView Corporate Reputation of Pharma 2025 survey.

Make sure you take part before it’s too late!

Here is the link to the survey: https://t.co/eTvbislh2F

[PatientView @PatientView]

PatientView sends warm wishes to those celebrating the #LanternFestival.
It's now the Year of the Fire Horse, and we encourage patient groups to drive positive change by participating in the Corporate Reputation of Pharma survey before 16th March: https://t.co/eTvbislh2F

[PatientView @PatientView]

#WorldObesityDay
Obesity is a complex, chronic condition affecting millions. Patient groups play a huge role in reducing stigma & advocating for better care. Show pharma how they need to improve by completing the 2025 Corporate Reputation of Pharma Survey https://t.co/LUwyL2yA7s

[PatientView @PatientView]

Patient groups, you have until 16th March to complete the PatientView Corporate Reputation of Pharma Survey!
How long does it take? Just a few minutes!
Why your voice matters: Your lived experience is essential to driving change.
Complete the survey today: https://t.co/SXOKRDnW0Q

[PatientView @PatientView]

We'd like to extend our sincere gratitude to the 71 Japanese patient groups who shared their perspectives in the 2024 Corporate Reputation of Pharma survey.
Have your say! Complete this year's survey by 16th March: https://t.co/eTvbislh2F

[PatientView @PatientView]

Thank you to the 1600 patient groups that have already completed the PatientView Corporate Reputation of Pharma 2025 survey.

Don't miss your chance to be heard, access the survey here in your preferred language: https://t.co/eTvbislh2F

[PatientView @PatientView]

How is your pharma company perceived by patient groups & how does this compare to other companies?
Every year, patient groups worldwide share their insights in the PatientView Corporate Reputation of Pharma survey.
Access the survey here in 23 languages: https://t.co/LUwyL2z7X0

[PatientView @PatientView]

This #WorldCancerDay, we thank the patient groups supporting cancer patients & loved ones.
The PatientView Corporate Reputation of Pharma survey gives patients a vital voice.
Now open - we're urgently calling on cancer groups worldwide to take part: https://t.co/2ncLtdglq6

[PatientView @PatientView]

Pharma companies know that strong relationships with patient groups are essential, yet this can be challenging.
Want to understand how patient groups perceive your organisation? Find out if your company is included in this year’s analytics: https://t.co/dxGYkvMVAs

[PatientView @PatientView]

Be part of the change & help shape the future of pharma.
The PatientView Corporate Reputation of Pharma Survey is now open to patient groups and will look at 47 pharma companies across 10 key indicators.
Complete the survey here in your preferred language: https://t.co/cCUh1NSpKw